Cargando…
Clinical implementation of whole-genome array CGH as a first-tier test in 5080 pre and postnatal cases
BACKGROUND: Array comparative genomic hybridization (CGH) is currently the most powerful method for detecting chromosomal alterations in pre and postnatal clinical cases. In this study, we developed a BAC based array CGH analysis platform for detecting whole genome DNA copy number changes including...
Autores principales: | Park, Sang-Jin, Jung, Eun Hye, Ryu, Ran-Suk, Kang, Hyun Woong, Ko, Jung-Min, Kim, Hyon J, Cheon, Chong Kun, Hwang, Sang-Hyun, Kang, Ho-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114015/ https://www.ncbi.nlm.nih.gov/pubmed/21549014 http://dx.doi.org/10.1186/1755-8166-4-12 |
Ejemplares similares
-
The clinical application of array CGH for the detection of chromosomal defects in 20,126 unselected newborns
por: Park, Sang-Jin, et al.
Publicado: (2013) -
Comprehensive chromosome analysis of blastocysts before implantation using array CGH
por: Chung, Mi Kyung, et al.
Publicado: (2013) -
Whole genome amplification and its impact on CGH array profiles
por: Talseth-Palmer, Bente A, et al.
Publicado: (2008) -
DNA Quality Assessment for Array CGH by Isothermal Whole Genome Amplification
por: Buffart, Tineke E., et al.
Publicado: (2007) -
Array-CGH and breast cancer
por: van Beers, Erik H, et al.
Publicado: (2006)